PHOE
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Phoenix Asia Holdings Limited is a holding company that conducts its operations through its wholly-owned subsidiary, Winfield Engineering (Hong Kong) Limited. The company specializes in substructure works in Hong Kong, providing services such as site formation, ground investigation, and foundation works. It operates primarily as a subcontractor within the civil engineering industry, with a business history dating back to 1990. The company is registered as a specialist contractor for foundation works, site formation, and ground investigation, as well as a subcontractor for foundation and piling activities including sheet piles, bored piles, driven piles, diaphragm walls, micro piles, and hand-dug caissons. In May 2026, the company entered into an agreement to acquire ACEA Pharma, Inc., a clinical-stage pharmaceutical company, though the transaction had not been completed as of the annual report date.

Summarised from the company's own disclosures, fiscal year ended Aug 2026

Industry Engineering & Construction Homepage winfield.hk
Sector Industrials IR page ir.winfield.hk
Tags
substructure works, site formation, ground investigation, foundation works, piling, civil engineering, subcontracting, Winfield Engineering (Hong Kong) Limited, Phoenix (BVI) Limited, ACEA Pharma Inc., ACEA Therapeutics Inc.
Press page —

Metrics

Valuation  
Market cap $ 396.36M
Market cap (USD) $ 396.36M
P/E -305.83
PEG —
P/BV 64.36
P/S 55.01
P/OCF -69.20
P/FCF 347.88
Dividend yield —
Turnover / mcap —
Returns  
ROE -25.9%
ROI -22.8%
ROIC -17.2%
Profit margin -16.7%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 15
Quality score -87.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023
Revenue 7.206M 7.371M 5.756M 2.228M
Net profit -1.201M 1.026M 1.057M 351.065K
Free cash flow — 1.139M 540.332K -79.719K

Figure FY 2026 FY 2025 FY 2024 FY 2023
Share price 15.22 — — —
P/OCF -57.41 — — —

Filed figures

Figure Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (USD) — 2.49M 1.63M 4.62M
↳ YoY growth -34.5% +183.1%
Lease liabilities (USD) — 51,174 25,054 65,295
Cash and deposits (USD) — 890,578 2.38M 892,525
Right-of-use assets (USD) — 28,914 5,894 51,518
Cash flow detail
Operating cash flow (USD) -57,112 540,332 1.18M -5.73M
Purchases of property, plant and equipment (USD) -22,607 — -41,086 —
Change in receivables (cash effect) (USD) -163,389 -1.49M 839,583 -2.99M
Change in payables (cash effect) (USD) -120,100 1.12M -122,303 -781,080
Interest paid (cash effect) (USD) -1,137 -820 -800 -800
Income taxes paid (cash effect) (USD) — 32,725 475,943 —
Operating cash flow before change in receivables (USD) 106,277 2.03M 340,861 -2.74M
Free cash flow (OCF - PPE - intangibles) (USD) -79,719 — 1.14M —
Income detail
Provision for credit losses (USD) — — 18,039 -214
Credit cost ratio (credit losses / average receivables) (%) — — 0.9% 0.0%
Reported Aug 12, 2025 Aug 12, 2025 Aug 14, 2026 Aug 14, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Termination of Stock Acquisition Agreement Bull 0 Bear 4 M&A

As previously reported in the Report on Form 6-K furnished by Phoenix Asia Holdings Limited (the “Company”) on May 4, 2026, the Company entered into a Stock Acquisition Agreement dated May 4, 2026 (the “Stock Acquisition Agreement”) with ACEA Pharma, Inc. (the “Target Company”) and ACEA Therapeutics, Inc. (the “Transferor”). Under the Stock Acquisition Agreement, the Company would have acquired all of the issued and outstanding equity interests of the Target Company in exchange for 100,000,000 newly issued ordinary shares of the Company. Closing was subject to customary conditions and regulatory approvals, including the expiration or termination of waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the receipt of any required approval from The Nasdaq Stock Market LLC (“Nasdaq”).

Section 11.1(b) of the Stock Acquisition Agreement permits either the Company or the Transferor to terminate the agreement after November 2, 2026 (the “Outside Date”), if closing has not occurred on or before the Outside Date and the terminating party has not materially breached the agreement, subject to the provisos in that section.

May 04, 2026

Hong Kong, May 04, 2026 (GLOBE NEWSWIRE) -- Phoenix Asia Holdings Limited (the “Company” or “Phoenix Asia”) (NASDAQ: PHOE), a Hong Kong-based company mainly engaged in substructure works, announces a significant update in its business development.

Phoenix Asia is pleased to announce entering into a stock acquisition agreement (the “Stock Acquisition Agreement”) with ACEA Pharma, Inc., an exempted company incorporated with limited liability in the Cayman Islands (“Target Company”) and ACEA Therapeutics, Inc., an exempted company incorporated with limited liability in the Cayman Islands (the “Transferor”) for the acquisition of 100% of the issued and outstanding shares of common stock of Target Company (the “Company Shares”). The Target Company is a clinical stage pharmaceutical company with a diverse product portfolio to address unmet medical needs in cancer, autoimmune disease, and Covid-19.

The Company is also pleased to announce entering into a convertible promissory note with a principal sum of $20,000,000.00 (the “Note”) with Phoenix Prosperity Investment Limited, the controlling stockholder of the Company (the “Holder”).

About the Stock Acquisition Agreement

On May 4, 2026, the Company entered into the Stock Acquisition Agreement with (i) the Target Company; and (ii) the Transferor. The Transferor holds 100% of the issued and outstanding equity interests of Target Company. Pursuant to the Stock Acquisition Agreement, at the Closing (as defined in the Stock Acquisition Agreement), the Company shall acquire all the issued and outstanding equity interests of the Target Company from the Transferor in exchange for the issuance by the Company to the Transferor of 100,000,000 newly-issued ordinary shares of the Company, the value of which was as agreed by the parties to be $1,000,000,000.00.

The closing of the Stock Acquisition Agreement is expected to take place in the second quarter of 2026, subject to the satisfaction of the customary closing conditions and the receipt of all necessary regulatory approvals, including without limitation, that (i) all applicable waiting periods (and any extensions thereof) under the Title II of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and all other applicable antitrust or merger control laws shall have expired or otherwise been terminated and (ii) the receipt of any approval, clearance, confirmation, or other determination from Nasdaq to the extent required in connection with the transactions contemplated by the Stock Acquisition Agreement (including with respect to any reverse merger, reverse takeover, change of control or similar review).

About the Convertible Promissory Note

On May 4, 2026, the Company issued the Note in favor of the Holder with a principal sum of $20,000,000.00. The Note has been issued as consideration for bona fide advisory and transaction support services provided by the Holder to the Company. The Note matures on the third anniversary of the date of issuance (subject to provisions regarding acceleration and voluntary conversion), does not accrue interest, and is convertible into ordinary shares of the Company at a conversion price of $10.00 per share. The issuance of the Note and the shares issuable upon its conversion is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”) pursuant to the exemption to registration provided under Regulation S promulgated under the Securities Act.

About Phoenix Asia Holdings Limited

Phoenix Asia Holdings Limited is a Hong Kong-based company mainly engaged in substructure works, such as site formation, ground investigation and foundation works, in Hong Kong. The Company strives to deliver unparalleled customer satisfaction, the highest standards of work and safety, and exceptional craftsmanship and environmental performance. The Company conducts its business through its wholly-owned Hong Kong operating subsidiaries, Winfield Engineering (Hong Kong) Limited. Subsequent to this acquisition, the Company intends to transform into a pharmaceutical-industry holding company.

For more information, please visit the Company’s website: https://ir.winfield.hk

.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, without limitation, statements regarding the satisfaction of closing conditions, the receipt of regulatory approvals (including approvals by Nasdaq), the timing and completion of the transaction and the conversion of the Note. These statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “aim”, “anticipate”, “believe”, “estimate”, “expect”, “going forward”, “intend”, “may”, “plan”, “potential”, “predict”, “propose”, “seek”, “should”, “will”, “would” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC, including risks discussed under the “Risk Factors” section in the Company’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission.

For more information, please contact:

Phoenix Asia Holdings Limited

Investor Relations Department

Email: [email protected]

Mar 31, 2026

Hong Kong, March 31, 2026 (GLOBE NEWSWIRE) -- Phoenix Asia Holdings Limited (“PHOE” or the “Company”) (Nasdaq: PHOE) is an exempted company with limited liability incorporated under the laws of the Cayman Islands with no material operations of its own. The Company, through its indirectly wholly-owned operating subsidiary, Winfield Engineering (Hong Kong) Limited, is engaged in substructure works, such as site formation, ground investigation and foundation works in Hong Kong. The Company today announced its unaudited financial results for the six months ended September 30, 2025.

First Half of 2025 Financial and Operating Highlights

| | ● | Total revenue decreased by 7.3% from US$3,789,610 to US$3,511,591 |

| | ● | Gross profit decreased by 31.4% from US$1,080,232 to US$741,443 |

| | ● | Net income and total comprehensive income decreased by 68.6% from US$631,441 to US$198,336 |

| | | |

Mr. Chi Kin Kelvin Yeung , Chief Executive Officer of the Company, commented, “In our operating history of approximately 35 years, we have focused on providing substructure works. We take pride in our portfolio in substructure works. In the six months ended September 30, 2025 we continue to provide quality substructure works to our customers and expand our business. Leveraging our established track record, our expertise in substructure operations and our experienced management team, we believe we are well-positioned to capture the growth of the substructure works market in Hong Kong and expand our business.”

FINANCIAL RESULTS

Revenue

Revenue decreased by 7.3% from US$3,789,610 for the six months ended September 30, 2024 to US$3,511,591 for the six months ended September 30, 2025. The decrease was primarily due to certain projects were completed for the year ended March 31, 2025.

Cost of revenue

Cost of revenue increased by 2.2% from US$2,709,378 for the six months ended September 30, 2024 to US$2,770,148 for the six months ended September 30, 2025. The increase was mainly due to additional work has been necessitated with variation orders for certain projects.

Gross profit and gross profit margin

The gross profits was US$741,443 for the six months ended September 30, 2025, as compared to the gross profit of US$1,080,232 for the six ended September, 2024, a decrease of US$338,789, or 31.4%.

The decrease in gross profit was mainly attributable to additional work has been necessitated with variation orders for certain projects, but the amounts of these variation orders are still under negotiation with the relevant customer.

Net income and total comprehensive income

Net income and total comprehensive income decreased by 68.6% from US$631,441 for the six months ended September 30, 2024 to US$198,336 for the six months ended September 30, 2025. The decrease was mainly due to the decrease in gross profit.

About Phoenix Asia Holdings Limited

Prompts

Phoenix Asia Holdings Limited (ticker PHOE), listed in United States.

ETFs Holding Phoenix Asia Holdings Limited

ETF Weight in ETF Shares Market value As of
IDYN 0.82% 17,569 $ 910.46K Nov 16, 2026
LCTD 0.10% 6,243 $ 323.524K Nov 16, 2026
ENHI 0.05% 223 $ 11.556K Nov 16, 2026